These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31660827)

  • 1. Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment.
    Järemo P; Jejcic A; Jelic V; Shahnaz T; Oweling M; Winblad B; Behbahani H
    Curr Alzheimer Res; 2019; 16(11):1050-1054. PubMed ID: 31660827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
    Mizoi M; Yoshida M; Saiki R; Waragai M; Uemura K; Akatsu H; Kashiwagi K; Igarashi K
    Clin Chim Acta; 2014 Mar; 430():150-5. PubMed ID: 24508996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.
    Cam M; Durieu E; Bodin M; Manousopoulou A; Koslowski S; Vasylieva N; Barnych B; Hammock BD; Bohl B; Koch P; Omori C; Yamamoto K; Hata S; Suzuki T; Karg F; Gizzi P; Erakovic Haber V; Bencetic Mihaljevic V; Tavcar B; Portelius E; Pannee J; Blennow K; Zetterberg H; Garbis SD; Auvray P; Gerber H; Fraering J; Fraering PC; Meijer L
    J Alzheimers Dis; 2018; 62(4):1663-1681. PubMed ID: 29504531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
    Sandebring A; Welander H; Winblad B; Graff C; Tjernberg LO
    PLoS One; 2013; 8(2):e55847. PubMed ID: 23409063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
    Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
    J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
    Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
    Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
    Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
    J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Aβ43 deposition patterns in the brains of aged dogs, sea lions, and cats.
    Takahashi K; Chambers JK; Takaichi Y; Uchida K
    J Vet Med Sci; 2022 Nov; 84(12):1563-1573. PubMed ID: 36288928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia.
    Lauriola M; Paroni G; Ciccone F; D Onofrio G; Cascavilla L; Paris F; Gravina C; Urbano M; Seripa D; Greco A
    Curr Alzheimer Res; 2018 Feb; 15(4):381-385. PubMed ID: 29125073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42.
    Jäkel L; Biemans EALM; Klijn CJM; Kuiperij HB; Verbeek MM
    Mol Neurobiol; 2020 Apr; 57(4):2131-2141. PubMed ID: 31953617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.
    Almdahl IS; Lauridsen C; Selnes P; Kalheim LF; Coello C; Gajdzik B; Møller I; Wettergreen M; Grambaite R; Bjørnerud A; Bråthen G; Sando SB; White LR; Fladby T
    Front Aging Neurosci; 2017; 9():9. PubMed ID: 28223932
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease.
    Kakuda N; Shoji M; Arai H; Furukawa K; Ikeuchi T; Akazawa K; Takami M; Hatsuta H; Murayama S; Hashimoto Y; Miyajima M; Arai H; Nagashima Y; Yamaguchi H; Kuwano R; Nagaike K; Ihara Y;
    EMBO Mol Med; 2012 Apr; 4(4):344-52. PubMed ID: 22354516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
    Verberk IMW; Slot RE; Verfaillie SCJ; Heijst H; Prins ND; van Berckel BNM; Scheltens P; Teunissen CE; van der Flier WM
    Ann Neurol; 2018 Nov; 84(5):648-658. PubMed ID: 30196548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.
    Brubaker WD; Crane A; Johansson JU; Yen K; Garfinkel K; Mastroeni D; Asok P; Bradt B; Sabbagh M; Wallace TL; Glavis-Bloom C; Tenner AJ; Rogers J
    Alzheimers Dement; 2017 Dec; 13(12):1397-1409. PubMed ID: 28475854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abeta46 is processed to Abeta40 and Abeta43, but not to Abeta42, in the low density membrane domains.
    Yagishita S; Morishima-Kawashima M; Ishiura S; Ihara Y
    J Biol Chem; 2008 Jan; 283(2):733-8. PubMed ID: 18024430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.